Mealey's (December 13, 2019, 1:29 PM EST) -- BOSTON — A federal district court erred in dismissing a lead plaintiff’s class action complaint for lack of standing to pursue federal securities law claims against a medical device maker and others stemming from the device maker’s alleged failure to disclose U.S. Food and Drug Administration concerns over a spinal-cord injury device the company had sought to market, shareholders argue in a recent appellant brief filed in the First Circuit U.S. Court of Appeals (Wang Yan, et al. v. ReWalk Robotics Ltd., et al., No. 19-1614, 1st Cir.)....